2019
Familiarity and acceptability of long-acting reversible contraception and contraceptive choice
Paul R, Huysman B, Maddipati R, Madden T. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice. American Journal Of Obstetrics And Gynecology 2019, 222: s884.e1-s884.e9. PMID: 31838124, PMCID: PMC7781163, DOI: 10.1016/j.ajog.2019.11.1266.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsBlack or African AmericanChoice BehaviorContraceptive Agents, HormonalContraceptives, OralDelayed-Action PreparationsDrug ImplantsFemaleHealth Knowledge, Attitudes, PracticeHispanic or LatinoHumansIntrauterine DevicesLong-Acting Reversible ContraceptionMarital StatusMedroxyprogesterone AcetateMiddle AgedPatient Acceptance of Health CareRecognition, PsychologyWhite PeopleYoung AdultConceptsOral contraceptive pillsContraceptive pillsIntrauterine deviceDepo-medroxyprogesteroneContraceptive choicesReversible contraceptionDepo-medroxyprogesterone acetateHealth center populationHealthcare provider visitsHormonal intrauterine deviceHigh acceptabilityMultivariable Poisson regressionQualified health centersPreference-sensitive decisionsReversible contraception methodsCopper intrauterine deviceInterviewer-administered surveySpecific contraceptive methodsChi-square testProvider visitsContraceptive counselingContraceptive careHealth centersContraception methodsContraceptive methods
2013
Characteristics Associated With Discontinuation of Long-Acting Reversible Contraception Within the First 6 Months of Use
Grunloh D, Casner T, Secura G, Peipert J, Madden T. Characteristics Associated With Discontinuation of Long-Acting Reversible Contraception Within the First 6 Months of Use. Obstetrics And Gynecology 2013, 122: 1214-1221. PMID: 24201685, PMCID: PMC4051392, DOI: 10.1097/01.aog.0000435452.86108.59.Peer-Reviewed Original ResearchConceptsLevonorgestrel intrauterine systemIntrauterine deviceEarly discontinuationCopper intrauterine deviceBaseline characteristicsIntrauterine systemReversible contraceptionFirst-line contraceptive optionRate of discontinuationLong-Acting Reversible ContraceptionLow socioeconomic statusContraceptive CHOICE ProjectMonths of useCohort studyDiscontinuation ratesContraceptive optionsUnintended pregnancyFrequent bleedingDiscontinuationIUD usersCost contraceptionCommon reasonYounger ageLogistic regressionTelephone interviewsSexually Transmitted Infection Prevalence in a Population Seeking No-Cost Contraception
McNicholas C, Peipert J, Maddipati R, Madden T, Allsworth J, Secura G. Sexually Transmitted Infection Prevalence in a Population Seeking No-Cost Contraception. Sexually Transmitted Diseases 2013, 40: 546-551. PMID: 23965768, PMCID: PMC3752093, DOI: 10.1097/olq.0b013e31829529eb.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBlack or African AmericanChlamydia InfectionsChlamydia trachomatisCohort StudiesContraceptionDemographyFemaleGonorrheaHumansMiddle AgedMissouriNeisseria gonorrhoeaeNucleic Acid Amplification TechniquesPrevalenceRiskSexually Transmitted DiseasesTrichomonas vaginalisTrichomonas VaginitisWhite PeopleYoung AdultConceptsChlamydia trachomatisCases of CTWhite womenStaff-administered questionnaireTransmitted Infection PrevalenceCurrent screening recommendationsContraceptive CHOICE ProjectBlack womenThird of participantsInfected womenContraceptive studyScreening recommendationsMultivariable analysisScreening guidelinesRisk factorsPrevalence ratesCost contraceptionMore infectionsPositive casesNeisseria gonorrhoeaeNucleic acid amplificationYounger ageCases of GCRisk profileOlder ageWeight change at 12 months in users of three progestin-only contraceptive methods
Vickery Z, Madden T, Zhao Q, Secura G, Allsworth J, Peipert J. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception 2013, 88: 503-508. PMID: 23582238, PMCID: PMC3951762, DOI: 10.1016/j.contraception.2013.03.004.Peer-Reviewed Original ResearchAdolescentAdultBlack or African AmericanCohort StudiesContraceptive Agents, FemaleDelayed-Action PreparationsDesogestrelDrug ImplantsFemaleFollow-Up StudiesHumansIntrauterine Devices, MedicatedLevonorgestrelMedroxyprogesterone AcetateMissouriProgestinsProspective StudiesUrban HealthWeight GainYoung Adult